Citigroup
COCP icon

Citigroup’s Cocrystal Pharma COCP Stock Holding History

Citigroup’s Portfolio COCP Stock Details COCP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1 Sell
1
-389
-100% -$401 ﹤0.01% 5853
2025
Q4 		$382 Sell
390
-663
-63% -$702 ﹤0.01% 5607
2025
Q3 		$1.32K Buy
+1,053
New +$1.63K ﹤0.01% 5584
2025
Q1 		– Sell
-3
Closed -$6 – 5653
2024
Q4 		$6 Buy
+3
New +$6 ﹤0.01% 5780
2019
Q2 		– Sell
-165
Closed -$5K – 7748
2019
Q1 		$5K Hold
165
– – ﹤0.01% 7414
2018
Q4 		$7K Sell
165
-125
-43% -$4.12K ﹤0.01% 7262
2018
Q3 		$9K Buy
290
+83
+40% +$3.71K ﹤0.01% 7376
2018
Q2 		$9K Buy
207
+83
+67% +$3.08K ﹤0.01% 7215
2018
Q1 		$9K Buy
+124
New +$7.74K ﹤0.01% 7074

Other funds holding COCP

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TC
T3 Companies New York $76.8M AUM
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Citigroup's COCP Position: Q1 2026 in Review

Citigroup reduced its Cocrystal Pharma (COCP) stake by 100% in Q1 2026, selling an estimated $401 and leaving 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #5853.

Citigroup first reported a position in COCP in Q1 2018 and has held it in 9 quarters since. The position peaked at $9K in Q3 2018. 26 funds tracked by Wall St. Rank hold COCP as of Q1 2026.

  • Citigroup held 1 share of Cocrystal Pharma worth $1 as of Q1 2026.
  • Citigroup sold 389 Cocrystal Pharma shares in Q1 2026, an estimated $401.
  • Cocrystal Pharma made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5853 holding.
  • Citigroup first reported a position in Cocrystal Pharma in Q1 2018 and has held it in 9 quarters since.
  • Citigroup's Cocrystal Pharma position peaked at $9K in Q3 2018.
  • 26 funds tracked by Wall St. Rank held Cocrystal Pharma as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.